Light Street Capital Management LLC Takes $60.74 Million Position in Astera Labs, Inc. $ALAB

Light Street Capital Management LLC acquired a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 125,750 shares of the company’s stock, valued at approximately $60,740,000. Astera Labs comprises approximately 6.7% of Light Street Capital Management LLC’s investment portfolio, making the stock its 2nd biggest holding.

A number of other hedge funds have also modified their holdings of the business. BlackRock Inc. purchased a new position in shares of Astera Labs in the 2nd quarter valued at approximately $6,609,581,000. Atreides Management LP increased its position in Astera Labs by 108.9% during the 1st quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock worth $368,890,000 after purchasing an additional 1,754,593 shares in the last quarter. Amundi grew its stake in Astera Labs by 1,298.6% in the 3rd quarter. Amundi now owns 1,421,263 shares of the company’s stock worth $278,283,000 after acquiring an additional 1,319,643 shares during the period. Artisan Partners Limited Partnership purchased a new stake in Astera Labs in the 4th quarter valued at about $148,980,000. Finally, Goldman Sachs Group Inc. grew its stake in shares of Astera Labs by 189.0% during the 4th quarter. Goldman Sachs Group Inc. now owns 1,312,927 shares of the company’s stock valued at $218,419,000 after buying an additional 858,693 shares during the period. 60.47% of the stock is currently owned by hedge funds and other institutional investors.

Astera Labs Stock Performance

Shares of ALAB stock opened at $290.30 on Thursday. The stock’s 50 day simple moving average is $347.19 and its 200 day simple moving average is $248.42. Astera Labs, Inc. has a twelve month low of $97.89 and a twelve month high of $499.48. The company has a market capitalization of $50.36 billion, a price-to-earnings ratio of 143.71 and a beta of 3.84.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, beating analysts’ consensus estimates of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The firm had revenue of $392.40 million during the quarter, compared to the consensus estimate of $360.85 million. During the same period in the prior year, the firm earned $0.44 EPS. The business’s revenue was up 104.5% on a year-over-year basis. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, analysts forecast that Astera Labs, Inc. will post 2.7 EPS for the current fiscal year.

Insiders Place Their Bets

In other Astera Labs news, COO Sanjay Gajendra sold 90,630 shares of the business’s stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $340.35, for a total value of $30,845,920.50. Following the transaction, the chief operating officer directly owned 1,119,038 shares in the company, valued at $380,864,583.30. The trade was a 7.49% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Manuel Alba sold 136,974 shares of the business’s stock in a transaction that occurred on Wednesday, July 1st. The stock was sold at an average price of $442.01, for a total value of $60,543,877.74. Following the completion of the transaction, the director directly owned 1,287,524 shares in the company, valued at $569,098,483.24. The trade was a 9.62% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 419,244 shares of company stock worth $163,135,169 in the last 90 days. 10.40% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

A number of analysts have recently issued reports on ALAB shares. JPMorgan Chase & Co. lifted their price objective on shares of Astera Labs from $205.00 to $280.00 and gave the company an “overweight” rating in a research note on Wednesday, May 6th. UBS Group reiterated a “neutral” rating and set a $425.00 price objective on shares of Astera Labs in a research note on Wednesday, August 5th. Northland Securities upgraded shares of Astera Labs from a “market perform” rating to an “outperform” rating and set a $350.00 price target for the company in a research report on Monday, August 17th. Needham & Company LLC boosted their price objective on Astera Labs from $260.00 to $425.00 and gave the stock a “buy” rating in a research report on Wednesday, August 5th. Finally, Zacks Research raised Astera Labs from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, August 11th. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and eight have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $333.00.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.